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INTRODUCTION 
Amniotic fluid which surrounds foetus in amniotic sac provides several 
benefits to the foetus. Despite several investigations, the regulation of amniotic fluid 
volume and composition remains incompletely understood. This results in part from 
the complexities in the amniotic fluid dynamics, an interaction of several sites of 
amniotic fluid secretion and excretion. 
The purpose of taking group of women with borderline oligohydramnios at 
third trimester pregnancies are because the aetiology, management and the outcome is 
different in late onset oligohydramnios compared to early onset oligohydramnios. The 
importance of amniotic fluid volume as an indicator of foetal status and 
oligohydramnios as an indicator of chronic hypoxia is a relatively recent development. 
Progressive improvements in ultrasound techniques have made it possible to 
assess the amniotic fluid volume accurately. Although subjective and semi 
quantitative methods of estimating amniotic fluid volume are in use, the best 
technique remains controversial. However, the technique of four quadrant method of 
calculating amniotic fluid index (AFI) described by Phelan et al. in 1987 is accepted 
by most of the authors. Numerous factors have been evaluated with respect to the 
effect on amniotic fluid index including interobserver and intraobsever variation, 
transducer pressure, maternal hydration, foetal movements, transducer type, 
presentation of foetus and number of gestation. 
Various methods have been described for antepartum and intrapartum foetal 
surveillance. They are NST, CST, FAST, BPP, VAST, doppler velocimetry, FHR 
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tracing, foetal stimulation test and foetal scalp blood pH estimation. All methods have 
their own advantages and disadvantages. 
Amniotic fluid is an important part of pregnancy and serves as an indicator of 
placental function on the foetal development. Its assessment is an essential part of 
evaluation of foetal health in terms of distress, meconium stained liquor, higher rates 
of caesarean delivery for a non reassuring foetal heart rate pattern and foetal growth 
restriction. Amniotic fluid is very crucial for the survival of the foetus and Amniotic 
Fluid Index (AFI) is the most common way for the estimation of amniotic fluid 
volume which is performed by ultrasound method.  
Studies have revealed that AFI is an accurate criterion for estimating adequate 
placental function. Amniotic fluid volume varies with gestational age. Any decrease 
or increase in volume of amniotic fluid leads to pregnancy complications. 
In most studies, Oligohydramnios has been defined as amniotic fluid index less 
than or equal to 5 cm & its associated maternal and foetal complications are proven. 
However there are different views about the range of Borderline AFI. In a study done 
by Phalen et al borderline AFI is defined between 5 and 8 cm. Also, Gumus and 
Miller have defined a borderline AFI as an AFI of 5.1-10. In spite of different views, 
in most reported studies, the pregnancies with borderline AFI have shown outcomes 
such as non reactive non-stress tests, foetal heart rate deceleration, meconium 
aspiration, immediate caesarean delivery, low Apgar score, LBW, NICU admission 
and SGA. 
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AIMS AND OBJECTIVES 
Objectives of the Study: 
1. To study the pregnancy outcome in borderline oligohydramnios 
2. To evaluate the value of AFI in predicting birth weight, foetal distress, 
meconium aspiration, foetal growth restriction, NICU admission. 
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REVIEW OF LITERATURE 
 Maryam Asgharnia et al., (2013) did cross sectional study in 235 pregnant 
patients and compared perinatal outcomes of pregnancies with borderline 
versus normal amniotic fluid index. There were no significant difference 
between two groups in diabetes, preeclampsia and neonatal respiratory 
distress. The borderline AFI group had higher neonatal complications such as 
LBW, IUGR, Apgar score of less than 7 & need for NICU admission, which is 
statistically significant. 
 Ashraf Jamal and collegues determined adverse pregnancy outcomes in 
borderline amniotic fluid index in term patients. They found that caesarean 
section rates were significantly higher in borderline AFI for non-reassuring 
foetal heart rate and increased incidence of birth weight less than 10
th
 
percentile. No significant difference in rate of NICU admission and meconium 
stained liquor in both groups. 
 
 
   Chamberlain et al. (1984) related qualitative amniotic fluid volume to 
perinatal outcome as determined at the time of last biophysical profile score 
assessment in 7583 referred high risk obstetric patients in a retrospective chart 
review. Gross and corrected perinatal mortality in association with normal 
qualitative amniotic fluid volume ranged from 4.65/1000 and 1.97/1000 
respectively to 187.5/1000 and 109.4/1000 in association with decreased 
qualitative amniotic fluid volume, respectively.
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 Crowley et al. (1984) in a study of prolonged pregnancies showed that patients 
with reduced amniotic fluid had a statistically significant increase in 
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meconium stained liquor and growth retarded babies and they were more likely 
to require delivery by caesarean section for foetal distress. There were no 
perinatal deaths and the perinatal outcome was satisfactory in both groups. 
Ultrasound measurement of amniotic fluid showed an effective discriminatory 
test in post term pregnancies.
2 
 Manning et al. (1986) defined severe oligohydramnios as a condition in which 
the largest vertical pocket of amniotic fluid measures less than 1 cm as 
determined by an ultrasound method, was observed in 113 patients in a 
population of 15,431 referred high-risk patients (0.7%). In all cases, 
intervention took place unless there was a recognized structural anomaly or 
extreme prematurity. Overall perinatal mortality was 132.7/1000 and the 
incidence of major anomaly was 13.3%. With intervention, corrected perinatal 
mortality rate was 17.7/1000, a rate not significantly different from that 
observed in the entire population. All end points of perinatal mortality were 
significantly increased in patients with severe oligohydramnios, in comparison 
with randomly selected controls with normal amniotic fluid. These findings are 
interpreted to indicate that oligohydramnios in a structurally normal foetus is 
an indication for delivery.
3 
 Brace R.A. and Wolf et al. (1989) studied 705 cases, the amniotic fluid trends 
in pregnancy were,
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o Amniotic fluid volume rises progressively till approximately 32 weeks. 
o After 40 weeks there is progressive decline in amniotic fluid volume at 
a rate of 8%. 
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o Oligohydramnios (<5th percentile) is approximately around <300ml and 
hydramnios (>95th percentile) varies from 1700-1900ml. 
 Rutherford et al. (1987) assessed amniotic fluid volume in 330 high risk 
pregnancies using a semi quantitative four quadrant technique and the amniotic 
fluid index and were evaluated in relationship to foetal heart rate testing and 
perinatal morbidity. An inverse relationship was found between the amniotic 
fluid index and non reactive non stress test, FHR decelerations, caesarean 
section for foetal distress, and low Apgar score, meconium staining,. More 
importantly, even if the NST was reactive, adverse perinatal outcome was 
significantly more frequent with diminished compared to normal amniotic fluid 
volume.
4
  
 Kumar et al. (1991) in their study evaluated amniotic fluid index in relationship 
to foetal heart rate and perinatal morbidity in 415 patients at term. They found 
an inverse relationship between AFI and NST, FHR decelerations and 
caesarean sections for foetal distress. The important finding was that, adverse 
perinatal outcome was significantly frequent with severity of oligohydramnios, 
even if the NST was reactive.
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 In a study, Grubb et al. (1992) found that decreased amount of amniotic fluid 
have been associated with adverse foetal outcome. Women with an AFI less 
than 2cm had operative intervention for foetal distress in 7 to 11 cases (64%) 
compared with 17 of 81(21%) who had an AFI of 2cm or more (p=0.005). 
They concluded that, the need for operative intervention for foetal distress is 
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increased in patients with prolonged FHR decelerations during ante partum 
testing when oligohydramnios is present.
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 Hoskin and associates (1991) interpreted variable decelerations noted during 
NST by adding estimation of amniotic fluid volume. The incidence of 
caesarean delivery for intrapartum foetal distress progressively increased 
coincidentally with severity of variable decelerations and diminished amniotic 
fluid volume. Severe variable deceleration during NST resulted in a 75% 
caesarean rates if AFI is 5cm or less.
6
 
  Devoe et al. (1994) compared NST, AFI and Doppler results in predicting 
intrapartum morbidity in high risk pregnancies and found that amniotic fluid 
index had the lowest sensitivity. The sensitivity ranged from
 
45% to 21 % with 
hypertension and post term pregnancies respectively. However this study has 
not been blinded.
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 Nageotte et al. (1994) concluded that the modified biophysical profile is good 
for foetal surveillance and identifies a group of patients at increased risk for 
adverse perinatal outcome and small for gestational age infants. Significant 
benefit is not found with contraction stress test compared with the BPP as a 
backup test.
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 Divon et al. (1995) studied the correlation between serial amniotic fluid index 
changes and adverse foetal outcome in post term pregnancies. Prominent 
changes in the amniotic fluid index had no association with adverse foetal 
outcome irrespective of the rate of change, provided, the final value remained > 
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5 cm. Significant foetal heart rate decelerations and meconium was detected in 
patients whose final AFI was< 5 cm.
12
 
 Barron C and colleagues (1995) compared pregnancies with low AFI and 
normal AFI on routine intrapartum amniotic fluid volume assessment. The 
variable decelerations and caesarean delivery for foetal distress occurred more 
in oligohydramnios because of less number of women who had crossed 40 
weeks of gestation and there was no difference in Apgar score or neonatal 
complications between two groups.
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 Schucker et al (1996) in the analysis of 136 pregnancies which were 
complicated by severe preeclampsia concluded that there is no association 
between the amniotic fluid index and caesarean sections for non reassuring 
foetal testing. However the study group had a large number of preterm patients 
and they also concluded that for women with severe preeclampsia remote from 
term, AFI < 5 cm is predictive of intrauterine growth restriction but lacks 
sensitivity.
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 Conway et al. (1998) has analysed whether the isolated oligohydramnios in 
term pregnancies is a clinical entity and have concluded that isolated 
oligohydramnios in normal term pregnancy does not indicate foetal 
compromise. So most women with isolated oligohydramnios, labour induction 
may not be needed as it merely increases the rate of caesarean section.
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 Weiner et al. (1996) did a study on central and peripheral hemodynamic 
changes in post term foetuses and its correlation with oligohydramnios and 
abnormal FHR pattern. Post term foetuses with an abnormal AFI had 
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significantly lower aortic peak velocity compared with foetuses with normal 
AFI. It was concluded that oligohydramnios and abnormal FHR pattern in post 
term foetuses appear to be associated with impaired cardiac functions. Poor 
foetal ventricular function due to failing heart leads to reduced renal perfusion 
and results in oligohydramnios.
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 Ergun A and colleagues (1998) analysed a study that amniotic fluid volumes 
were measured in 1,659 pregnant women to determine the predictive value on 
perinatal outcome. All cases were evaluated by other tests of foetal well-being. 
Among these women, 128 cases had oligohydramnios, and 1,531 cases were 
normal. In all cases, parameters assayed were foetal distress, mode of delivery, 
and meconium stained amniotic fluid, Apgar score and early-late neonatal 
complications. The results of the perinatal evaluation of oligohydramnios were 
as follows; in assessing foetal distress: specificity 94.2%, sensitivity 18.4%, 
positive predictive value 35.9%, negative predictive value 86.7% and accuracy 
82.8%, and in assessing low Apgar score the values were 93.0, 21.3, 95.9 and 
89.5%, respectively. As a result, measurement of the amniotic fluid volume is 
an important parameter predicting perinatal outcome, and its predictive value 
increases if it is combined with other foetal well-being tests with different end 
points.
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 Brost et al. (1999) conducted a study on the effect of foetal presentation on 
amniotic fluid index and concluded that the presentation of the foetus should 
also be considered in evaluating amniotic fluid index. Successful version from 
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breech to cephalic presentation resulted in significant increase in amniotic 
fluid index.
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 Chouhan et al. (1999) analysed 42 reports on amniotic fluid index published 
between 1987 to 1997 and concluded that AFI of 5 cm or less significantly 
increases the risk of either LSCS or foetal distress or low 5 min Apgar score 
(<7).
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 Magann et al. (1999) did a case control study of 79 women and compared for 
pregnancy complications with an AFI of < 5 cm and > 5 cm. They found that 
the two groups did not differ significantly in their risk for thick meconium, 
variable decelerations, amnioinfusion, caesarean delivery for foetal distress or 
umbilical artery pH less than 7.1.
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 Casey and colleagues (2000) conducted a retrospective study of 6423 
pregnancies and found that AFI < 5 cm was associated with significantly 
increased perinatal morbidity and mortality.
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 Magann and Chouhan et al. (1999) studied 1001 patients at risk, undergoing 
antenatal testing and concluded that, the current ultrasonographic measurement 
with amniotic fluid index and 2 diameter pocket technique are poor diagnostic 
tests to determine whether a patient is at high risk for an adverse perinatal 
outcome. They concluded that amniotic fluid index was a poor screening 
criterion for pregnancies at risk in case of presumed foetal distress.
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 Pierce et al (2000) summarized the results of 13 prospective trials of 
intrapartum amnioinfusion for meconium stained liquor and concluded that 
11 
 
infants treated with amnioinfusion were less likely to develop meconium 
aspiration and caesarean delivery rates were also low.
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 Raj Sriya and associates (2001) did a study to determine the value of amniotic 
fluid volume assessment at term on perinatal outcome. It was found that an 
increased incidence of meconium stained amniotic fluid, caesarean delivery for 
foetal distress, low birth weight and low Apgar scores in AFI < 5  cm group. 
They concluded that an AFI < 5 cm for detecting oligohydramnios is a 
valuable test.
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 Malhotra et al. (2002) analysed the effect of maternal oral hydration with 
hypotonic solution (water) on amniotic fluid volume. Fifty women were made 
to drink 2 litres of water in 1 hr. The mean AFI in the hydration group 
significantly increased by 2.01 + 2.73 cm. They concluded that maternal 
hydration status has a role in regulation of amniotic fluid volume.
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 Chandra P and associates (2000) used AFI for foetal surveillance and showed 
that amniotic fluid volume assessment is helpful in predicting the perinatal 
outcome. The incidence of birth asphyxia, neonatal complications, low 5 min 
Apgar score, LSCS for foetal distress were increased and mean birth weight 
was low.
22 
AFI had sensitivity of 76.92%, specificity 73%, positive predictive 
value 50%and negative predictive value of  99% in predicting caesarean 
section for foetal distress. 
 Lawrence Leeman and colleagues (2005) found that Oligohydramnios occurs 
in about 1% to 5% of pregnancies at term. Because adverse outcomes occur in 
high-risk pregnancies complicated by low amniotic fluid volume, 
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oligohydramnios commonly prompts labour induction. At one university 
centre, oligohydramnios is now the leading indication for labour induction. 
Labour induction increases the use of caesarean delivery, particularly for the 
primiparous woman with an unripe cervix. Recent studies questioning the 
safety of labour induction in women who have had a caesarean may increase 
the number of elective repeat caesarean procedures when delivery is believed 
indicated for oligohydramnios.
26
 
AMNION: 
               The cells of inner cell mass organise into hypoblast and epiblast. A cavity 
appears in epiblast and enlarges to form amniotic cavity. Amniotic sac develops from 
a space formed in primitive amnion adjacent to embryonic plate about 12 days post 
fertilisation. The sac enlarges and fuses with body stalk and chorion to produce 
amniotic sac. Amnion is the inner layer of foetal membranes. Its internal surface is 
smooth and in contact with liquor amnii. Outer surface consists of connective tissue 
and is apposed to chorion.They strip easily from foetal surface of placenta and can be 
separated from one another. It is 0.02-0.5 mm thick. The layers from inside outwards 
are cuboidal epithelium, basement membrane, a layer of reticular structure, 
fibroblastic layer, and spongy layer. It is metabolically active. It has no blood supply, 
nerve supply and lymphatic system. 
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Figure 1: Structure of amnion 
 DEVELOPMENT OF AMNIOTIC FLUID: 
              The amniotic fluid also known as pregnant woman‟s water or waters(Latin 
liquor amnii).It fills inside the amniotic cavity and surrounds the foetus. The origin of 
liquor amnii is not well understood till now. It is of both maternal and foetal origin. In 
early pregnancy, amniotic fluid is an ultra filtrate of maternal plasma, formed largely 
by transport across amnion. By second trimester, it consists mainly extracellular fluid 
which diffuses through foetal skin and reflects composition of foetal plasma. This is 
called “intramembranous pathway”. By 20th week, amniotic fluid is composed largely 
of foetal urine. Liquor is swallowed by the foetus and then passes on to maternal 
blood from foetal circulation through placenta. There is rapid exchange of liquor and 
gets replaced within 3- 4 hours. As pregnancy advances liquor is more diluted due to 
foetal urine. Osmolality decreases with increase in gestational age.Amnionic fluid also 
contains vernix caseosa, organic, inorganic contents (sodium, urea, protein) 
desquamated foetal cells, steroid and non-steroid hormones (cortisone, corticosteroids, 
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progesterone, estriol, human chorionic gonadotropin, human placental lactogen), 
carbohydrates, electrolytes, lecithin, phospholipids and cholesterol. Foetal lung 
maturity is assessed by lecithin: sphingomyelin ratio (L/S).  
 
Figure 2: Circulation of amniotic fluid 
Amniotic fluid is bacteriostatic. Pulmonary fluid also contributes along with fluid 
filtering through the placenta. Foetal saliva also contributes. Aquaporins 8 and 9 has a 
role in placenta water transfer. Goodlin et al have shown that, there is correlation 
between maternal plasma and liquor volume i.e. elevated maternal plasma volume is 
associated with polyhydramnios and decreased plasma volume is associated with 
oligohydramnios. Throughout pregnancy prostaglandin E1 and E2 have been found in 
amniotic fluid but F type seems to be present during labour.       
15 
 
 
 
Amniotic fluid volume differs at each week. It increases rapidly in first half of 
pregnancy and then it gradually increases. It peaks at 34 weeks. Then the amount 
diminishes after 36 weeks till term, wide range varying from 400 ml to 1000 ml. It 
decreases at a rate of 8% per week. In post term, very little liquor may be felt and 
further reduction occurs.   
 
Figure 3: Amniotic fluid index in normal pregnancy   
16 
 
 
Figure 4: Amniotic fluid volume in pregnancy 
Amniotic fluid flow can occur in two ways:   
 unidirectional: phasic and non phasic 
 bidirectional flow by simple diffusion between amniotic and maternal 
compartments. 
It is colourless, may look turbid due to vernix caseosa. Examination of liquor is 
useful in management of pregnancy related conditions. Normal colour change has 
clinical significance: 
 
17 
 
It also has value in clinical situations like metabolic diseases, sex-linked 
disease, premature rupture of membranes, ante partum foetal surveillance. 
Consumption: 
    It is mainly by foetal swallowing. It is recognised based on epidermal debris in 
meconium. Current studies with ultrasound showed that foetus chews, swallows 
during intrauterine life. The other potential way is by trans membranous and intra 
membranous pathway. Hormones also play a role. ADH and cortisol affects 
permeability of amnion.  
 
Figure 5: Consumption of amniotic fluid 
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Functions: 
 Protective cushion for foetus 
  Helps in proper musculoskeletal development 
  Control embryo‟s body temperature 
  Prevention of embryo adherence to amnion 
  Protects foetus from trauma 
  Promotes synthesis of surfactant 
  Development and maturity of lungs and gastrointestinal tracts. 
 Helps in lung expansion 
 Provides space for foetal movements 
  Prevents placental retraction and hence foetal asphyxia 
  Gives passive immunity to foetus because swallowed liquor might provide 
gamma globulin and antibodies 
 Hydrostatic wedge to help in dilatation of cervix during labour 
 Membrane rupture will help in augmentation of labour 
 It has anti-infective properties. 
ASSESSMENT OF AMNIOTIC FLUID VOLUME: 
Assessment of liquor as an indicator of foetal condition has gained importance 
in recent years because of improvement in ultra sonographic imaging. 
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1. Clinical assessment: 
Symphysiofundal height measurement and palpation of foetal parts remains an 
essential part in examination of pregnant women. However it is a poor predictor of 
true amniotic fluid volume even by experienced physician. 
2. Quantitative assessment: 
Instillation of paraamino hippurate (PAH) through amniocentesis and 
determination of liquor volume is most accurate and gold standard method of amniotic 
fluid measurement. Since it is invasive, it is of little significance. 
3. Semi quantitative assessment-ultra sonographically 
   i. Subjective assessment: 
     Visual assessment is based on relative amount of echo free spaces of fluid are 
compared with space occupied by foetus and placenta. It is a simple method. Highly 
trained observer is needed and numerical results are lacking
30
. 
  ii. Maximal vertical pocket: 
        Amniotic fluid assessment as described by chamberlain et al. 
AMNIOTIC FLUID VOLUME MAXIMUM VERTICAL POCKET(cm) 
Normal 2-8 
Increased >8 
Marginal 1-2 
Decreased <1 
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Figure 6:  Amniotic fluid in one quadrant 
AMNIOTIC FLUID INDEX: 
It is the best ultrasonographic method of measuring amniotic fluid volume.
 
Figure 7: Measurement of amniotic fluid index 
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AFI measuring method: 
 Supine position 
 Divide uterus into four quadrants by using umbilicus and Linea Nigra as 
reference points. 
 Transducer is placed in long axis in each quadrant parallel to floor of room. 
 Largest vertical unobstructed and clear pocket of amniotic fluid is measured. 
 It is repeated in four quadrants and sum of which will give amniotic fluid index 
in centimetres. Phelan criteria are universally accepted. 
 
Figure 8: Technique of measuring amniotic fluid index 
TABLE 1: AMNIOTIC FLUID INDEX (PHALEN): 
Normal 8 to 24 cm 
Oligohydramnios <5cm 
Borderline oligohydramnios 5.1cm to 8 cm 
Polyhdramnios >25cm 
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Moore and Cayle showed intra and inter observer variations of 5 & 10mm 
respectively in their study
37
. Four quadrant technique helps to minimize observational 
variability. 
Dildy et al showed that using para aminohippurate predicts actual volume of 
AFI with correlation coefficient of 0.84.
38 
Transducer pressure effect on AFI: 
Flack N.J. et al(1994) showed alteration in AFI by the pressure of transducer 
on abdomen. Low pressure increases AFI by 13% and 20% decrease in high 
pressure.
40 
Foetal movement effect on AFI: 
Wax et al showed that mean change of AFI was 1.5 + 0.1 cm due to shifting of 
amniotic fluid in quadrants during foetal movements.
39 
Foetal presentation effect on AFI: 
Brain C et al showed an increase in amniotic fluid index from mean of 12.06 + 
3.15 to 15.19 + 3.35 cm following external cephalic version in breech presentation. So 
it is important to consider presentation for evaluation of AFI.
11 
Amniotic fluid indices in twin pregnancies: 
 
Amniotic fluid indices obtained in twin pregnancies are comparable in 
singleton pregnancies. Although the twin pregnancies have lower liquor volume than 
singleton pregnancies, difference is not clinically significant. Lyndon M et al in twin 
23 
 
A and twin B, found a mean AFI 13.6 cm and 13.7 cm respectively, which is 
comparable to singleton pregnancies.
41 
AFI is preferred in sonographic evaluation because 
1. It will assess the total amount of fluid in the cavity and not a single pocket. 
2. The curve of AFI is similar to that generated from dye dilution technique. 
3. More sensitive in detection of oligohydramnios than single vertical pocket. 
4. It is standardised to reduce interobserver variations. 
5. Amniotic fluid measurement can be followed on subsequent examinations. 
Amniotic fluid derived stem cells (AFS): 
Amniotic fluid stem cells which are newly discovered may not be pluripotent. 
If grown in correct environment, it can become muscle cells, fat cells, bone cells or 
liver cells. AFS cells typically double every 36 hours, so it can be grown in large 
quantities. It does not require feeders from other stem cells. It resembles human 
embryonic stem cells. 
OLIGOHYDRAMNIOS 
It occurs in 0.5 to 4% of all pregnancies. It is defined as amniotic fluid volume 
less than expected gestational age or volume below 5
th
 percentile for specific 
gestational age or reduction in AFI below 500 ml. At term volume will be less than 
300 ml. Complete absence of amniotic fluid is called anhydramnios. 
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Various methods are available in third trimester for assessment of adequacy of AF: 
Manning and platt (1979): one centimetre pocket (minimum) 
Chamberlain et al (1984): two centimetre pocket (minimum) 
Crowley, o‟ Herlihy (1984): three centimetre vertical pocket (at least one) 
Phalen et al (1987): four quadrant method. 
Between 36-42 weeks, AFI less than 5 cm is defined as oligohydramnios and AFI 
between 5 to 8 cm as borderline oligohydramnios. (Phalen et al) 
ETIOLOGY: 
Depend on time of onset, there are two basic types
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:
 
1. Early onset 
2. Late onset - mainly due to placental insufficiency 
Exact cause is not known. 
Maternal factors: 
 Severe pregnancy induced hypertension 
 Membrane rupture 
 Post dated pregnancy 
 Medications: ACE inhibitors, long term use of NSAIDs, thiazide diuretics. 
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Placental factors: 
 Chronic abruption 
 Donor sac in twin to twin transfusion syndrome 
Foetal factors: 
 Bilateral renal agenesis 
 Multicystic dysplastic kidneys 
 Obstruction of urinary system 
 Non renal anomalies: neural tube defects, skeletal dysplasia 
 Chromosomal anomalies: trisomy 18 
 
Figure 9: Renal agenesis causing oligohydramnios 
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Iatrogenic: 
 fluid leak due to chorionic villous sampling and amniocentesis 
 
Figure 10: Chorionic villous sampling 
Idiopathic: 
No cause can be found in <10% cases. In these cases there is higher incidence 
of foetal viral infection. The hypothesis is that spontaneous rupture of amniotic 
membrane with intact chorion. The amniotic fluid is reabsorbed into extra amniotic 
space, hence no loss of fluid per vaginum. 
Premature membrane rupture: 
It occurs in 2-4 % of preterm gestations. There is an 80% chance of labour or 
infection, if it occurs before 24 weeks. There is chance of 54% perinatal mortality and 
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in survivors 40% risk of permanent handicap. Diagnosis is made by demonstrating 
liquor in speculum examination. Even in normally functioning foetal bladder, patient 
can present initially as oligohydramnios in a pregnancy complicated by PROM. The 
risk of foetal pulmonary hypoplasia is more if PROM occurs in early pregnancy. 
PROM in later pregnancy carries risk of cord compression. It will cause variable 
decelerations. It can be treated with amnioinfusion, which will relieve cord 
compression. 
Post dated pregnancy: 
Incidence is 3-7% of all pregnancies. It has higher incidence of perinatal 
morbidity, mortality and macrosomia. It is a leading cause for obstetric malpractice 
litigation with involvement of neurologically impaired babies. Amniotic fluid 
composition will change in post term pregnancies. It becomes milky and there is 
abundant vernix caseosa. 
   In post dated pregnancies, oligohydramnios is increased due to shift in normal rates 
of fluid production, resorption and increased sensitivity of tubules to vasopressin. It 
may also be due to placental aging and progressive maturation of renal function with 
advancing gestation. Foetuses will be at increased risk for meconium aspiration, 
umbilical cord compression and foetal compromise. Occurrence of spontaneous 
decelerations due to oligohydramnios necessitates prompt delivery.  
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Figure 11: Meconium aspiration syndrome 
Twin pregnancy: 
In twin pregnancies 75% are dichorionic and 25% are monochorionic. As a 
result of twin to twin transfusion syndrome, foetal loss is higher in monochorionic 
twins. Donor twin becomes anaemic, growth restricted and develops oligohydramnios.  
When oligohydramnios become severe, foetus becomes immobilised due to pressure 
from sac with polyhydramnios. This is called trapped twin syndrome. Monochorionic 
twins are identified by “T sign”. The first manifestation of syndrome is an increased 
nuchal translucency at 10-14 weeks gestation in one or both foetuses. Subsequently, 
there is intertwin disparity of AF volume at 15-17 week gestation by folding of 
intertwin membrane. 
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There is serious danger to the foetus with oligohydramnios in multiple 
pregnancies. If complication occurs before 26 weeks, there is death of all foetuses in 
spite of various attempted therapies. Endoscopic laser ablation is recommended for 
twin to twin transfusion syndrome. After viability, amniodrainage from twin of 
polyhydramnios sac will improve AF volume of oligohydramnios twin sac. 
 
Figure 12: One twin with oligohydramnios and the other with polyhydramnios 
Congenital malformation: 
Clinician‟s should always rule out congenital and structural abnormalities 
while managing oligohydramnios. Urogenital system malformation is common and 
the classic is potters syndrome. Along with renal agenesis they have low set ears and 
facial pressure deformities. With low AFI, imaging foetus will be very difficult. 
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Transabdominal amnio-infusion can help in imaging. It can be associated with 
posterior urethral valve syndrome or ureterocystic junction obstruction. It can be 
detected as early as 14-16 weeks gestation. Oligohydramnios is unlikely, if problem is 
unilateral. Trisomy 21 and 18 will also have cystic kidneys and renal pelvis dilatation, 
so karyotype should be determined. 
 
Figure 13: Potters syndrome 
Intrauterine growth restriction: 
It occurs in 3-7% of all pregnancies. There is chance of higher incidence of 
hypoxia, meconium aspiration and acidosis. Impaired growth development and 
necrotising enterocolitis can occur after birth. 
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Approximately 60% IUGR foetuses have decreased AF volume. This is very 
useful to differentiate pathologically growth restricted foetus from constitutionally 
small foetus. Thorough evaluation is indicated when oligohydramnios is associated 
with IUGR, since it is a sign of foetal jeopardy. 
 
Figure 14: IUGR baby compared with normal baby with same gestational age 
Fluid leak following procedures: 
It affects less than 1% of pregnancies undergoing CVS or amniocentesis. In 
almost all the patients, following a period of bed rest, leaking stops and fluid returns 
to normal. 
Uteroplacental insufficiency: 
It is one of the important causes in third trimester for oligohydramnios. It is 
associated with hypertension, antiphospholipid antibody syndrome. In FGR foetus, 
abdominal circumference is below 5
th
 percentile for gestational age. It lags behind 
head circumference. So there is elevated HC/AC ratio. Increased resistance in Doppler 
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helps to associate oligohydramnios with uteroplacental insufficiency. Decrease in 
renal and pulmonary blood flow cause decrease in urine output and lung secretion and 
thus decrease in AF volume. Thus oligohydramnios may represent chronic foetal 
hypoxia. 
Diagnosis: 
Clinical diagnosis is by easy palpation of foetal parts, fundal height will be 
small for gestational age and uterus feels full of foetus and difficulty in foetal head 
ballottement. Usually foetus is in breech presentation and hyper flexed attitude. Foetal 
heart sounds will be easily heard. Thorough maternal history to rule out rupture of 
membrane should be obtained. If history is suggestive of rupture of membranes, 
speculum examination is performed to look for vaginal pooling of liquor along with 
fern testing.  History of medication intake should be asked for. Oligohydramnios is 
also associated with pre eclampsia; hence BP measurement and protineuria should be 
evaluated. Absence of amniotic fluid while doing artificial rupture of membrane is 
suggestive of oligohydramnios. 
In early onset oligohydramnios, detailed sonographic assessment is needed to 
evaluate foetus. However, decrease in amniotic fluid and hyper flexed attitude of 
foetus makes it difficult. Hence following additional procedures are needed: 
1. Dye amnio infusion 
2. Diagnostic amnio infusion 
3. Furosemide challenge test 
4. Colour Doppler 
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Combination of wave forms may be of help in diagnosis of oligohydramnios
44
: 
 High resistance Doppler wave forms and absent end diastolic flow in umbilical 
artery is suggestive of placental insufficiency. 
 High resistance uteroplacental waveform and normal umbilical artery 
waveform is indicative of placental insufficiency. 
 Low resistance uteroplacental waveform and absent end diastolic velocity in 
umbilical artery is indicative of primary foetal cause. 
 Low resistance uteroplacental waveform and normal umbilical artery is more 
likely rupture of amniotic membranes. 
 
Figure 15: Uterine artery doppler 
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Complications: 
 Preterm labour 
 Breech presentation due to less space in amniotic cavity 
 Skeletal abnormalities due to pressure effect (talipes equino varus, potters 
facies, congenital amputation of limbs) 
 Formation of amniotic bands and adhesions 
 IUGR 
 Foetal distress(due to meconium aspiration, cord compression, secondary to 
growth restriction) 
 Pulmonary hypoplasia 
 NICU admission 
 Still birth 
 
Figure 16: CTEV due to oligohydramnios 
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Figure 17: Placenta smeared with meconium 
 
Figure 18: Amniotic band due to oligohydramnios 
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Figure 19: Abnormal presentation due to oligohydramnios 
Management: 
Management is determined mainly by its aetiology. It is necessary for careful 
assessment of both mother and foetus. The treatment of primary disease like 
placement of vesico-amniotic shunt in case of posterior urethral valves will help in 
amniotic fluid volume to return to normal.  
Early diagnosis and treatment in selected euploid foetus with functioning renal 
tissue with amnio infusion will prevent pulmonary hypoplasia and foetal survival rate 
will improve. IUGR is managed with ante partum testing and optimal time for 
delivery is determined. Corticosteroids and antibiotics are used in case of preterm 
rupture of membranes in < 32 weeks. Because of its association with foetal hypoxia, 
oligohydramnios is important. 
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If foetus is term and at risk of adverse perinatal outcome, pregnancy is to be 
terminated. In post term pregnancy, termination of pregnancy is needed. Maternal 
hydration will be unlikely to improve amniotic fluid in the long term. 
Maternal hydration (oral or intravenous hypotonic fluid) will transiently 
increase AF volume and it is less invasive than amnioinfusion. Oral hydration reduces 
plasma osmolality and sodium concentration, thereby causes osmotically driven 
maternal-to-foetal water flux. IV hydration will increase mean velocity of uterine 
artery and thereby increase in utero placental perfusion. 
During labour, oligohydramnios increases the chance of cord compression. 
Consequently, foetus should be closely monitored by variable decelerations. Persistent 
variable decelerations may by ameliorated by amnioinfusion. However, it is not used 
in clinical practice routinely. Acute foetal distress might require immediate vaginal or 
caesarean delivery depending upon circumstances.  
  Borderline AFI: Close daily surveillance is indicated. 
  AFI less than 5 cm: Depending upon clinical situation and foetal maturity, consider 
delivery by induction or caesarean section. 
   Most studies [Mark 1995, Grubb and Paul 1992, Jayanti Kar et al. 2000] showed 
that decrease in AFI is associated with increased incidence of operative deliveries, 
foetal distress, low Apgar score and increased perinatal mortality. 
  
38 
 
Role of amnioinfusion: 
Oligohydramnios and consequent cord compression in labour may be 
associated with deceleration of FHR, foetal hypoxia and distress requiring caesarean 
section. 
 
Figure 20: Amnioinfusion technique 
 This procedure involves infusion of normal saline or ringer‟s lactate into 
uterine cavity to replace amniotic fluid. It can be used as diagnostic or therapeutic 
procedure. 
Indication: 
 To prevent pulmonary hypoplasia in severe oligohydramnios, it is to be done 
serially before 28 weeks at weekly interval. 
 Helps in USG imaging in patients with oligohydramnios 
 For correction of oligohydramnios 
 To reduce foetal distress 
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 To administer antibiotics in chorioamnionitis 
 To correct variable deceleration 
It can be done in two ways: Trans cervical or Trans abdominal. Double lumen 
catheter is used. Even though it is expensive but helps to monitor uterine contractions. 
Instead we can even use 20-22 gauge needle.  
Infusate should not be at room temperature because it can cause foetal 
bradycardia. Body temperature is more physiologic. 
Recent studies have suggested that intra partum saline fusion reduces the risk of 
foetal distress. Amnio infusion relieves umbilical cord compression and improves the 
perinatal outcome in presence of thick meconium stained liquor, by diluting the 
meconium and reduce the risk of meconium aspiration. 
However, amnioinfusion in absence of FHR tracing abnormalities in thick 
meconium stained liquor has no advantage. Nageotte and Co-workers (1991) found 
that prophylactic amnioinfusion resulted in significantly decrease in frequency and 
severity of variable decelerations in labour, however there was no improvement in the 
caesarean delivery rate.
47 
Sponge and associates (1994) also proved that prophylactic 
amnio infusion will dilute the meconium but did not improve the perinatal outcome.
48 
Method: 
         Volume infusion for borderline oligohydramnios (AFI 5-8 cm): 250 ml and for 
AFI less than 5 cm: 500 ml 
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It is done under local anaesthesia. USG is done to identify a pool of amniotic 
fluid devoid of cord. Under aseptic precaution, catheter or needle is guided. Position is 
confirmed by injecting 1-2 m of infusate to visualize fluid turbulence or by aspirating 
amniotic fluid. Continuous or intermittent infusion can be done at a rate of 20 to 30 
ml/min. Repeat infusion can be done weekly. Infusion of 250 ml saline increases AFI 
by 4.3 plus or minus 1.5 cm. If efflux of infusate is blocked, there is a small risk of 
uterine rupture. Foetal tissue biopsy is recommended before or after amnio infusion 
for rapid karyotyping. 
FETAL SURVEILLANCE 
Since the estimation of amniotic fluid volume is used in foetal surveillance and 
it is an important parameter used in Biophysical profile scoring system it is necessary 
to discuss briefly about other surveillance tests. 
Number of tests is used for antepartum foetal surveillance. No single testing 
modality should be regarded as exclusive choice for foetal surveillance because these 
tests reveal different aspects of foetal patho physiology often in a complimentary 
manner.  Further work is also needed to determine the optimal integration of various 
other surveillance methods for improving the perinatal outcome in a cost effective 
manner. 
Foetal movement assessment: 
Monitoring foetal movements serve as an indirect measure of CNS functions. 
Various methods used to quantify foetal movements and to see foetal well being are 
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maternal subjective perception, Doppler ultrasound, toco dynamometer and real time 
ultrasound. 
Maternal subjective perception: 
The oldest and simplest method to monitor foetal well being is charting of 
mothers perception of foetal movements. Studies have shown that there is significant 
correlation between number of movements perceived by mother and those confirmed 
by ultrasound. For example: Rayburn found that 80% of all movements seen during 
ultrasound monitoring were perceived by mother.
49 
Daily foetal movement charting is an adjunct to antepartum foetal Surveillance 
and it also helps in determining the frequency of surveillance tests, in predicting 
abnormal FHR pattern. 
 
Figure 21: Foetal kick count chart 
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NST – non stress test: 
NST is the most widely used primary method for assessment of foetal well-being. It is 
also been incorporated into the BPP scoring system. It will show FHR accelerations in 
response to foetal movements, as a sign of foetal health. It is based on the hypothesis 
that heart rate of the foetus who is non-acidotic will temporarily accelerate in response 
to foetal movements.  „  
 
 
 
Figure 22: Non stress test 
NST classification: 
Category 1: Baseline rate of 110-160 bpm  with moderate baseline variability(6-25 
bpm) with acceleration which requires minimum of two at least 15 beats per minute 
from base line to the peak, lasting for at least 15 seconds  in conjunction with foetal 
movements during a 20min period. Loss of reactive pattern is most commonly 
associated with sleep cycle.  Late or variable decelerations should be absent. Early 
decelerations may be present or absent. Extension of this test to 80-120 min reduces 
the incidence of non reactive NST by 50%.
50
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Category 2:  Indeterminate FHR tracings: It may show any one of the following: 
                       Tachycardia 
                       Baseline with absent, minimal or marked variability 
                       Recurrent variable decelerations with minimal to moderate variability 
Recurrent late decelerations with moderate variability 
Category 3:  Sinusoidal wave pattern or absent variability with one of the following:  
                     Recurrent late deceleration 
                     Recurrent variable decelerations 
                     Bradycardia                             
Deceleration during NST: 
According to ACOG, variable deceleration during NST, which is brief, is not a 
sign of foetal compromise. In contrast, repetitive variable decelerations have been 
associated with increased risk of caesarean delivery and the risk is even more if 
associated with low AFI. Apart from nonreactive
 
pattern, repetitive variable 
decelerations, poor beat to beat variability of less than 5
 
bpm, late decelerations with 
spontaneous uterine contractions are associated with evidence of uteroplacental 
pathology. 
 
 
Figure 23: Deceleration in NST 
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Predictive value: 
        A reactive NST followed by foetal death within one week at a rate of 
approximately 4-5 / 1000 tests and the incidence is more if oligohydramnios is 
present. Hence reactive NST does not give long term prognostic implications. A 
reactive NST indicates foetus that is not stressed by hypoxia. Therefore it is not 
guarantee against subsequent foetal death and hence the need for repeated NST. NST 
for adverse foetal outcome has high specificity of 90-95% but sensitivity is only about 
50%. But it is still used widely both as a diagnostic and screening test. 
The CST- Contraction stress test: 
        In this method stress is applied by eliciting uterine contraction which causes 
intermittent interruption of blood supply and uncovers the utero placental 
insufficiency by producing late decelerations and variable decelerations in presence of 
oligohydramnios. These contractions are elicited either by oxytocin infusion (oxytocin 
challenge test) or by Nipple stimulation. Positive CST correlates with adverse 
perinatal outcome. It has low false negative rates and its findings parallel the 
intrapartum methods. It is an acute indicator of oxygen and acid base status rather than 
a long term predictor of neurological outcome. The false positive rates for CST 
average 30%. Further, it needs about 90 min and cannot be used in whom uterine 
activity is contraindicated. The non-invasive methods like BPP are comparable with 
CST in terms of outcome and interventions. 
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Foetal acoustic stimulation test (FAST): 
In a randomized controlled study, Smith and colleagues showed that the non-
reactive NST reduced from 14% to 9% following FAST.
51
 All data support that FAST 
is as reliable as reactive NST and it also reduces the testing time. FAST has also been 
used in intrapartum foetal assessment when there is abnormal FHR pattern in place of 
foetal scalp blood sampling or prior to it. In a study by Smith and colleagues 41% of 
foetuses with abnormal pattern responded with reactive pattern and none of them were 
acidotic and 53% of those who did not respond were found to be acidotic.
51 
It is also used as admission test and to get favourable positions on ultrasound 
examination. FAST is clinically safe. 
Biophysical profile: 
Manning and colleagues in 1980, proposed the use of biophysical variables on 
ultrasound for antepartum foetal surveillance.
52
For each variable a score of 0 or 20 is 
given. Among all variable amniotic fluid volume is the most important marker of 
chronic foetal distress. A score of 8 to 10 denotes good foetal health while score 4 or 
less which is measured 6 hours apart indicates need for immediate delivery and is 
significantly associated with low umbilical venous blood pH. 
Manning and colleagues reported 1 death per 1000 following normal test 
results during intrapartum period. The perinatal mortality varies from nil to 60%, 
when all variables are normal or abnormal respectively. Further as the score decreases, 
the perinatal morbidity rates increase progressively. These tests required 30-60 
minutes.  
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Modified biophysical profile (MBPP): 
        As the classical BPS system requires more time, the NST and amniotic fluid 
volume assessment was introduced which is called modified biophysical profile. Here, 
Amniotic fluid index is measured instead of maximum vertical pocket and less than 5 
cm is considered abnormal. This test requires only 10 min. ACOG has concluded that 
MBPP is an accepted method of antepartum foetal surveillance. 
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Vibro Acoustic Stimulation Test (VAST): 
Dr. Damania developed vibro acoustic stimulation test from mumbai.
53 
It uses 
ultrasound to evaluate the foetal response to acoustic stimulation. A both acute and 
chronic marker of uteroplacental insufficiency is assessed. So, VAST evaluation is 
done. 
I. Chronic responses indicates foetal growth, amniotic fluid index 
II. Sympathetic responses denotes startle response, Accelerations 
III. Behavioural state response indicates breathing, movements 
The observation time after vibroacoustic stimulation is 10 minutes. VAST has 
sensitivity of 87.9%, specificity of 77.8%, and positive predictive value of 86.4% and 
false negative rate of 12%. 
 
Figure 24: Vibro acoustic stimulation test 
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Doppler velocimetry: 
       Umbilical artery doppler is most commonly used. The S/D ratio more than 95th 
percentile for gestational age, absent or reversed end diastolic flow indicates increased 
impedance and foetal growth restriction is associated with it. Zelop and colleagues 
(1996) reported that the perinatal mortality rate for reversed end diastolic flow is 33% 
and for absent diastolic flow is 10%.
54  
Hence, absent or reversed end diastolic flow 
and umbilical venous pulsations have bad prognosis for foetus. 
When foetal hypoxemia occurs, foetus has compensatory mechanism, which 
increases the blood flow to brain (Brain sparing effect). The ratio of middle cerebral 
arterial RI to umbilical arterial RI <1 is considered to be indicator of foetal 
compromise and early evidence of FGR. 
Williams and colleagues have found that Doppler velocimetry and NST are 
equivalent to predict pregnancy outcome.
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 ACOG (2000) has concluded that 
umbilical artery velocimetry in conditions other than IUGR where it has been 
recommended as an adjunct to other techniques of foetal surveillance has no benefit. 
Computerized analysis of antepartum CTG: 
Dawes et al (1991) introduced software system to analyse the CTG recordings 
from a standard antenatal monitor. The usefulness of computerized analysis of CTG in 
screening and clinical management awaits larger studies. 
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Significance of foetal testing: 
         There has been a race for the development of a testing modality which can 
accurately detect a foetus going to be compromised, which itself speaks about the 
dissatisfaction associated with prevailing methods. 
The basic question asked is does the antenatal forecasting really make a 
difference? Does it prevent foetal damage? Platt and co workers (1987) reviewed the 
impact of foetal testing since 1971 to 1985 at Los Angeles country hospital and 
concluded that the testing was clearly beneficial because foetal death rate was 
significantly less in the tested high risk pregnancies compared with the rate in those 
non tested.
56
 Todd and co workers (1992) concluded that by the time foetal 
compromise is diagnosed with antenatal testing foetal damage has already been 
sustained.
57 
Inspite of these limitations various tests are being used by clinically an 
attempt
 
to reduce perinatal mortality and morbidity.
 
Admission test: 
      This is a screening test for the state of oxygenation of the foetus at the time of 
admission of the mother in labour room. It will help to choose the appropriate type of 
intrapartum surveillance and allow more rational utilization resources. The procedure 
is similar to NST. 
Intrapartum foetal monitoring: 
        Various methods have been used for foetal monitoring during labour are 
intermittent auscultation, cardio tocography, foetal stimulation tests, foetal scalp blood 
pH, umbilical blood gas analysis, Doppler, foetal ECG and pulse oximetry. 
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Cardio tocography: 
Electronic foetal heart rate monitoring can be done by either internal or 
external electrodes. We have to look for baseline heart rate, variable accelerations and 
decelerations and tocography includes frequency of contractions, strength of 
contraction and foetal movements.  
Rate: 
Normal baseline heart rate of 110-160 bpm is generally considered. 
Bradycardia is defined as baseline FHR less than 110 bpm though lower normal limit 
is controversial. FHR between 100-120 bpm is not usually considered to represent 
foetal compromise in the absence of other changes and often attributed to head 
compression in occipitoposterior and transverse positions.  Causes of severe 
bradycardia (< 80 bpm) are hypothermia, prolonged hypoglycaemia, β blocker, 
congenital heart block, conduction analgesia. 
Tachycardia, if FHR > 160 bpm which may be due to foetal hypoxia, anaemia, foetal 
heart failure, chorio amnionitis. This signifies foetal compromise only in presence of 
concomitant decelerations. 
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Figure 25: NST showing tachycardia 
 
Variability: 
The variation of baseline foetal heart rate as a result of sympathetic and 
parasympathetic interaction is recorded as irregularities on the graph paper are called 
baseline variability. 
Short term variability: It is a measure of interval between cardiac systoles and 
shows instantaneous changes in foetal heart rate from one beat-to the other beat. 
Long term variability: Denotes oscillatory changes that occur during 1 min which 
results in waviness of FHR tracing at frequency of 3-5 cycles per min.  
52 
 
 
Figure 26: Reactive CTG 
Periodic changes: 
Acceleration: It is an increase in FHR of 15 bpm for 15-20 sec. It represents foetal 
alertness or arousal state. It is a reassuring pattern of NST. 
Decelaration-3 types: 
Early deceleration: It begins early in uterine contractions and returns to baseline 
before completion of contraction. This is mainly due to head compression and also 
associated with foetal hypoxia or acidosis. 
Late Deceleration: A smooth gradual decrease in FHR beginning at or after the peak 
of the uterine contraction and returns to baseline only after contraction ceased.  
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Figure 27: Late deceleration in NST 
 
Variable deceleration:  Most common deceleration pattern encountered during labour. 
It is defined as apparent abrupt decrease in rate, onset varying with successive 
contractions. Often it is due to cord compression. It will have shoulder of acceleration 
before and after the deceleration or may have abrupt deceleration. This variation is 
due to varying degree of cord occlusion. Occlusion of only the umbilical vein reduces 
the foetal blood return which triggers baroreceptor mediated acceleration. Subsequent 
complete occlusion due to obstruction of umbilical artery will result in foetal systemic 
hypertension. This stimulates baroreceptor mediated decelerations. The after coming 
shoulder of accelerations in reverse represents same event. The ACOG (1995) defined 
significant variable deceleration of those less than 70 bpm and lasting for more than 
60 sec.
58 
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Figure 28: Variable deceleration due to cord compression
 
 
55 
 
Prolonged Decelerations: It is defined as an isolated deceleration lasting more than 2 
min but less than 10 min. Common causes are uterine hyperactivity, cord 
entanglement, supine hypotension, cervical examination and epidural analgesia.  
 
 
Figure 29: prolonged deceleration 
 
Sinusoidal heart rate: This pattern of foetal heart rate has a stable baseline FHR of 
120-160 bpm, amplitude of 5-15 bpm, with fixed or flat short term variability, 
oscillation of waveforms above or below the baseline with no accelerations. 
This is observed in serious foetal anaemia of any cause. It is also seen in mepheridine 
and morphine therapy, foetal distress and umbilical cord compression.  
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Figure 30: Sinusoidal heart rate pattern 
Intrapartum stimulation tests: 
It is developed to overcome the disadvantages of FBS during labour in 
evaluating foetuses with suspicious FHR traces. 
1. Scalp Stimulation Test: It can be done by firm digital pressure or gentle pinch 
by an a traumatic Allis tissue forceps. If acceleration is observed, it is 
associated with pH > 7.2. Conversely if foetus fails to respond, only 30-40% 
would have pH below 7.2. 
2. Vibro acoustic stimulation: It is used as an alternative to FBS. About 50% of 
non responders would have scalp pH < 7.2, hence may require FBS. Most non-
acidotic foetuses show FHR acceleration.  
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Foetal Scalp Blood Sampling: 
        Measurement of pH may help to identify acidotic foetus in capillary scalp blood. 
If pH is > 7.5, labour can be observed. If pH is between 7.2 and 7.25, it is to be 
repeated after 30 min. If pH is less than 7.2 it is repeated immediately and if acidosis 
is confirmed, delivery is conducted promptly. The greatest benefit of FBS is reduced 
caesarean delivery. The disadvantages are its invasive, cumbersome, unacceptable 
time requirement, necessity of repeating, needs high skill and sophisticated 
equipment, immediate laboratory facility, risk of liquor contamination, etc. 
Other intrapartum foetal surveillance tests include 
1. Foetal electrocardiography 
2. Foetal Pulse Oximetry 
3. Doppler flow.  
 
Figure 31: Foetal scalp blood sampling 
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MATERIALS AND METHODS 
The study was conducted in department of Obstetrics and Gynaecology, PSG 
hospitals, Coimbatore for a period of twelve months. 
STUDY DESIGN: 
Case control study 
STUDY POPULATION: 
Antenatal mothers admitted in PSG hospitals with borderline oligohydramnios 
in third trimester and normal antenatal mothers with corresponding gestational age. 
SELECTION CRITERIA: 
Inclusion Criteria: 
 1. Singleton pregnancy 
 2. AFI between 5.1 to 8 cm 
               3. Antenatal mothers in third trimester 
Exclusion Criteria: 
              1. Medical co morbidities like diabetes, hypertension, overt hypothyroid 
              2. Pre eclampsia 
              3. Multiple pregnancies 
             4. Premature rupture of membranes 
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This study consists of an analysis of pregnancy outcome in 60 cases with 
diagnosis of borderline oligohydramnios by ultrasound in third trimester compared 
with 60 controls with normal AFI and matched for other variables like age, parity and 
gestational age. 
The study and control group consists of antenatal mothers admitted in 
PSGIMS&R, obstetrics and gynaecology department, Coimbatore. This is an 
observational case control study. 
Only those women who remembered their date of last menstrual period with 
previously regular menstrual cycles (only women with excellent dates) were taken for 
study.  
Ultrasound examination for amniotic fluid index was done by four quadrant 
amniotic fluid measurement technique. Women with borderline AFI will be taken for 
this study. For all the selected cases, thorough history, clinical examination was taken.  
For each case, control was taken with similar gravidity, parity & gestational age. 
Evaluation Plan:  
 Complication due to oligohydramnios 
 Non reassuring NST 
 Mode of delivery 
 Meconium aspiration 
 Foetal growth restriction 
 APGAR score 
 NICU admission 
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The management protocol was similar in both study group and control group. 
Those women, who had high risk factors like non reactive NST, were induced 
using dinoprostone gel (PGE2) or oxytocin. Women with no other risk factors were 
allowed for spontaneous onset of labour. All were monitored by continuous electronic 
foetal monitoring in labour. The nature of amniotic fluid noted at artificial rupture of 
membrane which was done in all women and was classified as clear and meconium 
stained liquor. Those who developed significant variable decelerations and repetitive 
late decelerations or other ominous FHR pattern with or without meconium stained 
liquor which persisted inspite of corrective measures like change in maternal position, 
hydration, O2 inhalation and stopping oxytocin were delivered by LSCS or 
instrumental delivery. All newborns were attended by neonatologists and endotracheal 
intubation was done in presence of thick meconium stained amniotic fluid. 
Various outcome measures recorded were, induced Vs spontaneous labour, 
gestational age at delivery, nature of amniotic fluid, FHR tracings, mode of delivery, 
indication for caesarean section or instrumental delivery, Apgar score, birth weight, 
admission to neonatal ward, perinatal morbidity and perinatal mortality. The results 
were recorded and tabulated. 
PERINATAL OUTCOME: 
Perinatal outcome is mainly assessed by Apgar score immediately after birth. It 
is assessed at 1 minute and 5 minutes of birth of baby. Admission to NICU 
immediately following delivery is also considered as criteria and Apgar scores were 
analysed among both groups. 
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RESULTS 
During this study period, 60 cases with diagnosis of borderline oligohydramnios by 
ultrasound in third trimester were compared with 60 controls with normal AFI and 
matched for other variables like age, parity and gestational age. There were no 
significant differences between the two groups regarding maternal age, gestational age 
and parity. 
TABLE 2: AGE DISTRIBUTION OF PATIENTS 
 N=120 MEAN (years) 
CASE 60 25.38 
CONTROL 60 24.60 
 
In our study, age less than 20 were 3 in both case and control group. Above 30 years 
of age were 4 in study group and 1 in control group. Majority were between 20 to 30 
years of age group. It was 53 in study group and 56 in control group. 
The mean age for study group was 25.38 years and that of control group was 24.6 
years. There was no difference in the mean age between two groups statistically. 
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TABLE 3: GRAVIDITY DISTRIBUTION 
GRAVIDITY GRAVIDA 1 GRAVIDA 2 GRAVIDA 3 
CASE 40 14 6 
CONTROL 54 6 0 
 
 
Figure 32: Bar diagram showing gravidity distribution  
In study group, primi mothers and multi mothers were 66.7%, 33.3% 
respectively. In control group, primi and multi mothers were 90%, 10% respectively. 
These are not statistically significant. 
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DISTRIBUTION OF GESTATIONAL AGE 
 
Figure 33: Gestational age distribution 
85% cases were term, whereas 15% cases were preterm. In controls, 95% were 
term and 5% were preterm. Gestational age distribution between controls and groups 
were not statistically significant. 
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ANTENATAL COMPLICATIONS 
TABLE 4: COMPLICATIONS IN ANTENATAL PERIOD 
 CASES (out of 60) CONTROLS (out of 60) 
IUGR 12 4 
INCREASED S/D RATIO 2 1 
 
 
 
Figure 34: Bar diagram showing antenatal complications 
 
The occurrence of IUGR and increased systolic/diastolic ratio were 20 % and 
3.3 % respectively in study group and 6.7 % and 1.7% in control group respectively, 
which is statically significant  (p<0.05). 
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INDUCED vs. SPONTANEOUS LABOUR 
 
 
Figure 35: Comparison of induction and spontaneous labour 
 
The labour was induced in 50 (83.3%) women with Borderline AFI and 44 
(73.3%) women with normal AFI. The decision for induction or allowing for 
spontaneous labour was made depending upon AFI, gestational age, presence of 
complications like IUGR and increased S/D ratio. The difference between two groups 
in this category was not statistically significant. 
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NON STRESS TEST PATTERN 
 
 
Figure 36: Foetal status assessment in NST 
 
The non stress test showed late decelerations in 18 (30%) women with AFI 5-8 
cm compared to only 7 (11.7%) in control group. There was significant difference 
between two groups in occurrence of foetal distress (P<0.05). 
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NATURE OF AMNIOTIC FLUID 
 
 
Figure 37: Colour of amniotic fluid 
 
The amniotic fluid was meconium stained in 14 (23.3%) and clear in 46 
(76.7%) women in study group. In control group, only 6(10%) women had meconium 
stained amniotic fluid and 54 (90%) had clear amniotic fluid. The difference in 
occurrence of meconium stained amniotic fluid between two groups was statistically 
significant. (p<0.05) 
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MODE OF DELIVERY 
 
 
Figure 38: Bar diagram depicting mode of delivery 
 
TABLE 5: Comparison of mode of delivery between cases and controls 
 CASE   CONTROL 
NORMAL VAGINAL DELIVERY 32 47 
INSTRUMENTAL DELIVERY 8 6 
LSCS 20 7 
 
Caesarean section was done in 20 (33.3%) women and instrumental delivery in 
8 (13.3%) women. The corresponding values for control group were 7(11.7%), 6 
(10%) respectively. The difference was statistically significant (P=0.009). This study 
shows that borderline oligohydramnios cases are going for LSCS quite high. 
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INDICATION FOR LSCS 
 
 
Figure 39: LSCS indication 
 
In our study cases went for L.S.C.S. due to foetal distress was 25%, in control 
group LSCS is 10% due to foetal distress. Whereas LSCS rate due to non progression 
of labour was same in both groups (5%). 
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APGAR SCORE 
 
Figure 40: Comparison of Apgar score between cases and controls 
TABLE 6: Apgar score 
 CASE CONTROL 
APGAR 7-9 54 (90%) 58 (96.7%) 
APGAR 5-7 4 (6.7%) 2 (3.3%) 
APGAR <5 2 (3.3%) 0 (0%) 
 
The Apgar score was not statistically significant in study and control groups. 
(P=0.24). 
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BIRTH WEIGHT 
 
 
Figure 41: Association of birth weight in borderline oligohydramnios 
 
The occurrence of birth weight < 2.5 Kg was seen in 17 (28.3%) and 4 (6.7%) 
in study group and control group respectively.  The difference was statistically 
significant (P<0.05). 
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ADMISSION TO NICU 
TABLE 7:  NICU admission 
 CASE CONTROL 
NICU ADMISSION 19 5 
NO ADMISSION 41 55 
 
 
 
Figure 42: Bar diagram showing babies who needed NICU admission 
 
19 neonates of study group were admitted to neonatal ward for various 
morbidities like birth asphyxia and meconium aspiration. Only 5 (8.3%) of control 
group were admitted to neonatal ward. The difference in the two groups was 
statistically significant (P < 0.05). 
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DISCUSSION 
Many studies have been done to correlate association of borderline 
oligohydramnios with adverse perinatal outcomes and the occurrence of maternal and 
foetal complications were reported high in pregnancies with borderline 
oligohydramnios than those with normal AFI. 
Totally 120 pregnant women were participated in this study. 
In Group I: 60 pregnant patients with isolated borderline oligohydramnios 
In Group II: 60 pregnant women with normal AFI 
In group I and II we compared age, parity, gestational age, any complication 
due to borderline AFI, induction of labour, foetal distress in NST, mode of delivery, 
colour of liquor, birth weight, Apgar score and NICU admission. Patients admitted 
with premature rupture of membranes were excluded from study. 
Both the groups were similar with respect to maternal age, parity and gravidity similar 
to study conducted by Gumus et al and Voxman et al. 
In this study, most often complications encountered were IUGR and increased 
S/D ratio in pregnancies with borderline oligohydramnios, which is consistent with 
the study by Banks who considered the likelihood of IUGR up to 4 times greater and 
Gumus et al found a greater rate of IUGR, LBW.  
Induction of labour does not make a difference when compared to study and 
control group. All patients who have not gone into labour at 40 weeks were induced in 
both the groups and some of the patients with borderline AFI also gone into 
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spontaneous onset of labour. Most of these patients were induced primarily with 
PGE2 gel. Some of these patients were only augmented with oxytocin. 
The non reactive non stress test rates are high in women with AFI 5.1 to 8 cm. 
The rate of non reactive NST is 30% in present study and is comparable to that similar 
study conducted by Kumar P et al. 1991which was 40%. NST showed variable and 
late decelerations in patients with borderline AFI when compared to pregnant patients 
in control group which was statistically significant in this study. Only 2 patients who 
had thick meconium stained liquor were treated with amnioinfusion and delivered 
vaginally. 
The occurrence of meconium stained amniotic fluid is high in women with 
borderline AFI. Meconium stained liquor was noted in 23.3% in study group in 
present study which is similar to other studies. In the study conducted by Grubb et al 
99% of women with low AFI and prolonged deceleration had meconium stained 
amniotic fluid. 
Various studies show different rates of LSCS for foetal distress in pregnant 
women with amniotic fluid index of 5.1 - 8 cm. The LSCS for foetal distress was done 
in25% in present study. Borderline oligohydramnios has been used as a screening test 
for the development of foetal distress, subsequently during intrapartum period. 
Apgar score <7 is only about 10% in present study which is not statistically 
significant when compared to control group.  
The mean birth weight is less in borderline oligohydramnios group. The 
occurrence of low birth weight is 28.3% which is comparable with other Indian 
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studies. (Chandra P et al 61.53 and Sriya R et al. 58.38%). The high incidence of low 
birth weight may be because of chronic placental insufficiency causing foetal growth 
restriction. 
31.7 percent of newborns were admitted in neonatal ward for various 
morbidities like birth asphyxia, meconium aspiration etc. This is not consistent with 
studies by Magann et al (1995) and Casey et al (1999). However, both authors refer to 
admission to neonatal intensive care units. Study by Sriya R et al (2001) showed even 
higher incidence of (88.88%) admission to neonatal ward. In a study by Maryam 
Asgharnia, infants with apgar <7 were routinely observed in NICU after delivery and 
that might contribute to higher rates of NICU admission. 
There were no foetal malformations in the present study. Though Borderline 
oligohydramnios can cause CTEV due to compression; to know the significance of 
association it needs large number of cases. 
In our study there was no perinatal mortality. In Chandra P et al. study neonatal 
death occurred in one case. In study by Baron et al. and Casey et al. there was no 
mortality probably because of good neonatal intensive care facilities. 
In current research, the incidence of respiratory distress between the two 
groups(borderline AFI and normal AFI) were not significant whereas there was a 
significant difference among patients between 28 to 32 weeks of gestational age, 
which might be because of premature births in this group. Also in other studies, there 
were increased incidence of respiratory distress in borderline AFI group and it was 
mostly because borderline AFI was evaluated in lower gestational age. 
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The limitations of study include the following: 
1. Only 60 cases were analysed in the study which exactly satisfied inclusion and 
exclusion criteria. 
2. The diagnosis of foetal distress was made depending on FHR tracings. 
However the foetal acidosis was not proved by foetal scalp blood sampling 
because of non –availability. 
3. The use of backup surveillance methods like amnioinfusion would have altered 
the outcome. 
4. The availability of better neonatal intensive care unit facilities probably would 
have minimized the neonatal death rates. 
5. Lack of neonatal follow up after 7 days. 
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CONCLUSION 
 In presence of borderline oligohydramnios, the occurrence of non reactive 
NST, abnormal FHR tracings during labour, meconium stained liquor, 
development of foetal distress, the rate of LSCS, low birth weight are high. (In 
our study, low 5 min Apgar score and perinatal mortality number is not 
statistically significant in study and control groups.) 
 Determination of AFI can be used as an adjunct to other foetal surveillance 
methods. It helps to identify those infants at risk of poor perinatal outcome. 
 Determination of AFI is a valuable screening test for predicting foetal distress 
in labour requiring caesarean section. It has a sensitivity of 71% and negative 
predictive value of 82% specificity of 58% and positive predictive value of 
43%. 
 Due to adverse outcomes in patients with borderline AFI and there was no 
sufficient evidence and specific decision regarding delivery based on 
borderline AFI, there should be close observation and they will need 
antepartum surveillance. 
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STATISTICAL METHODS 
Descriptive and Inferential statistical analysis is carried out in this study. 
Results on continuous measurements are represented as Mean+/-SD and results on 
categorical measurements are represented as numbers (%). 
Data collected from patients were initially entered into Microsoft excel-sheet 
and analysed using SPSS software. Pearson chi-square was used to compare the 
association between borderline oligohydramnois and foetal and maternal outcomes. A 
predictive value of less than 0.05 was taken as statistically significant. 
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 APPENDIX 
PROFORMA 
TITLE: “MATERNAL AND PERINATAL OUTCOMES OF PREGNANCIES 
WITH ISOLATED BORDERLINE OLIGOHYDRAMNIOS VERSUS 
UNCOMPLICATED NORMAL AMNIOTIC FLUID INDEX” 
Name  : 
AGE  : 
Gravida : 
Gestational Age  : 
Antenatal Complications : 
 
AFI: 
FETAL DISTRESS: 
INDUCTION: 
 
MODE OF DELIVERY: 
IF CS, INDICATION: 
COLOUR OF LIQUOR: 
SEX & WEIGHT OF BABY: 
APGAR SCORE: 
ADMITTED TO NICU: 
 
  
 PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS  
 
I __Dr.P.NITHYA____, am carrying out a study on the topic:   “MATERNAL AND 
PERINATAL OUTCOMES OF PREGNANCIES WITH ISOLATED BORDERLINE 
OLIGOHYDRAMNIOS VERSUS UNCOMPLICATED NORMAL AMNIOTIC 
FLUID INDEX” as part of my research project being carried out under the aegis of 
the Department of:  OBSTETRICS AND GYNAECOLOGY, PSG IMSR 
My research guide is:  Dr. KANCHANAMALAI  MD.,OG 
 
The justification for this study is:   
This study is undertaken to know the adverse pregnancy outcome and perinatal 
outcome in a women with borderline oligohydramnios. 
The objectives of this study are:  
 To study the pregnancy outcome in borderline oligohydramnios. 
 To evaluate the value of AFI in predicting foetal distress, meconium aspiration 
and foetal growth restriction.  
Sample size: _120_____. 
Study volunteers / participants are (specify population group & age group):   
Antenatal women in third trimester with borderline amniotic fluid index and normal 
antenatal mothers with corresponding gestational age. 
Location: _PSG HOSPITAL ___.   
We request you to kindly cooperate with us in this study. We propose collect 
background information and other relevant details related to this study. We will be 
carrying out:   
 
Initial interview (specify approximate duration):_____10_____ minutes.   
 Data collected will be stored for a period of fifteen years. We will not use the data as 
part of another study.  
 
Benefits from this study: nil 
Risks involved by participating in this study:  No major risks 
How the results will be used:  Can show positive correlation or negative correlation 
If  you are uncomfortable in answering any of our questions during the course of 
interview, you have the right to withdraw from the study. Kindly be assured that your 
refusal to participate, if you so decide, will not result in any form of compromise or 
discrimination in the services offered nor would it attract any penalty. You will 
continue to have access to the regular services offered to a patient. The information 
that we collect shall be used for approved research purposes only. You will be 
informed about any significant new findings - including adverse events, if any, – 
whether directly related to you or to other participants of this study, developed during 
the course of this research which may relate to your willingness to continue 
participation.  
Consent: The above information regarding the study, has been read by me/ read to me, 
and has been explained to me by the investigator/s. Having understood the same, I 
hereby give my consent to them to interview me. I am affixing my signature / left 
thumb impression to indicate my consent and willingness to participate in this study 
(i.e., willingly abide by the project requirements).   
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:   
 
 
Signature of the Interviewer with date:       Witness:  
 
Contact number of PI: 9629159591 
Contact number of Ethics Committee Office:  0422 2570170 Extn.: 5818 
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S.NO AGE GA G COMPLN AFI  INDUC NST-DSTRDELIVERYLIQUOR APGAR BABY WT NICU
1 28 0 1 0 6.4 0 1 2 1 0 1 1
2 30 0 1 0 6.8 1 0 2 0 0 0 0
3 21 0 1 1 7.1 1 0 0 0 0 1 0
4 23 0 1 0 6.4 0 0 0 0 0 0 0
5 21 0 1 0 6.6 1 0 0 0 0 0 0
6 19 0 1 1 7.8 1 0 0 0 0 1 0
7 24 0 2 1 7.2 1 0 2 1 0 1 1
8 23 1 1 1 6 1 0 0 0 0 1 0
9 27 0 1 0 7 1 1 2 1 0 1 1
10 21 0 2 0 6.9 1 0 1 0 0 1 0
11 29 0 1 0 5.5 1 0 0 0 0 0 0
12 26 0 2 0 6.1 1 1 2 1 0 0 1
13 21 0 1 0 7 1 1 1 1 1 0 1
14 23 0 1 0 7.4 1 0 0 0 0 1 0
15 29 0 3 0 6.5 0 0 0 0 0 0 0
16 25 0 1 0 6.2 1 0 0 0 0 0 0
17 24 1 1 2 6.5 1 0 2 1 0 1 1
18 24 0 1 0 6.6 1 1 2 1 2 0 1
19 26 0 1 0 5.9 1 0 1 0 0 0 0
20 23 0 1 0 6.6 1 1 2 1 0 0 1
21 22 0 1 0 7.7 1 0 0 0 0 0 0
22 21 0 1 0 6.7 1 0 1 0 0 0 0
23 29 0 1 0 6.9 1 1 0 1 1 0 1
24 26 0 2 0 5.4 1 1 2 0 0 0 0
25 23 0 1 1 6.6 1 0 0 0 0 0 0
26 30 0 1 0 7.6 1 1 2 1 0 0 0
27 26 0 1 0 5.7 1 0 1 0 0 0 0
28 27 0 1 0 7.9 1 1 0 1 0 0 1
29 25 0 1 0 6.5 1 0 0 0 0 1 0
30 25 0 2 0 6 1 0 2 0 0 0 0
31 30 1 2 1 5 1 0 0 0 0 1 0
32 25 0 1 0 7 1 1 2 0 0 0 0
33 23 0 1 0 6 1 0 0 0 0 0 0
34 24 0 1 0 8 0 1 2 1 0 0 1
35 28 0 3 0 8 1 0 0 0 0 0 0
36 24 0 1 1 6.8 1 0 0 0 0 1 0
37 22 0 2 0 6.9 1 0 0 0 0 0 0
38 18 1 1 1 5 1 0 2 0 0 1 1
39 27 0 1 0 8 1 0 0 0 0 0 0
40 20 0 1 0 7.5 1 1 2 0 0 0 0
41 30 0 1 0 5.3 1 0 0 0 0 0 0
42 26 1 1 0 5.4 1 0 0 0 0 0 0
43 22 0 3 0 7 0 0 0 0 0 0 0
44 33 0 3 0 7.5 0 0 0 0 0 0 0
45 27 0 2 0 7 1 0 0 0 0 0 0
46 26 0 3 1 6 1 0 0 0 1 0 1
47 21 0 1 0 7.8 1 0 0 0 1 0 1
48 25 0 1 0 6 1 0 0 0 0 0 0
49 29 1 1 1 6.4 1 1 2 1 2 1 1
50 24 0 2 0 6.7 0 0 0 0 0 0 0
51 29 0 1 0 7.9 1 0 0 0 0 0 0
52 34 0 2 0 7 1 0 2 0 0 0 0
53 27 1 2 1 7 1 0 0 0 0 1 1
54 19 0 1 0 7.5 1 0 1 0 0 0 0
55 28 0 1 0 6.3 0 1 2 0 0 0 0
56 32 1 3 2 5.8 0 0 2 0 0 1 1
57 32 1 2 1 7 1 1 2 0 0 1 1
58 28 0 2 0 7.5 1 1 1 1 0 0 1
59 23 0 1 0 6 1 0 0 0 0 0 0
60 26 0 2 0 7 0 1 1 0 0 0 0
CASE 
S.NO AGE GA G COMPLN AFI INDUCN NST-DSTRDELIVERYLIQUOR APGAR BABY WT NICU
1 28 0 1 0 N 1 0 1 0 0 0 0
2 26 0 1 0 N 1 0 0 0 0 0 0
3 30 0 2 0 N 0 0 0 0 0 0 0
4 26 0 1 0 N 1 1 1 0 0 0 0
5 24 0 1 0 N 0 0 0 0 0 0 0
6 22 0 1 0 N 1 0 0 0 0 0 0
7 21 0 1 0 N 1 0 0 0 0 0 0
8 25 0 1 0 N 1 1 2 1 0 0 1
9 22 0 1 0 N 0 0 0 0 0 0 0
10 26 1 2 1 N 1 0 0 0 0 0 0
11 24 0 1 0 N 0 0 0 0 0 0 0
12 29 1 2 2 N 1 1 2 1 1 1 1
13 19 0 1 0 N 1 0 0 0 0 0 0
14 25 0 2 0 N 1 0 0 0 0 0 0
15 23 0 1 0 N 1 0 0 0 0 0 0
16 20 0 1 0 N 0 0 0 0 0 0 0
17 24 0 1 0 N 0 0 0 0 0 0 0
18 21 0 1 0 N 0 0 0 0 0 0 0
19 22 0 1 1 N 0 0 0 1 0 0 0
20 26 0 2 0 N 0 0 0 0 0 0 0
21 29 0 1 0 N 1 0 0 0 0 0 0
22 30 0 1 0 N 1 0 0 0 0 0 0
23 24 0 1 0 N 1 0 0 0 0 0 0
24 25 0 1 0 N 1 0 0 0 0 0 0
25 26 0 1 0 N 1 0 0 0 0 0 0
26 28 0 1 0 N 1 0 2 0 0 0 0
27 23 0 1 0 N 1 0 0 0 0 0 0
28 22 0 1 0 N 0 0 0 0 0 0 0
29 19 0 1 0 N 1 0 1 0 0 0 0
30 24 0 1 0 N 1 0 0 0 0 0 0
31 23 0 1 0 N 1 0 0 0 0 0 0
32 22 0 1 0 N 1 0 0 0 0 0 0
33 21 0 1 0 N 1 0 0 0 0 0 0
34 21 0 1 0 N 1 0 1 0 0 0 0
35 22 0 1 0 N 1 0 0 0 0 0 0
36 24 0 1 1 N 1 0 0 0 0 1 0
37 23 0 1 0 N 1 0 0 0 0 0 0
38 25 0 1 0 N 1 0 0 0 0 0 0
39 24 0 2 0 N 1 0 0 0 0 0 0
40 26 0 1 0 N 1 0 0 0 0 0 0
41 27 0 1 0 N 1 0 0 0 0 0 0
42 28 0 1 0 N 1 1 1 0 0 0 0
43 28 0 1 0 N 1 0 0 0 0 0 0
44 30 0 1 0 N 1 1 2 1 0 1 1
45 21 1 1 1 N 1 1 2 1 1 1 1
46 28 0 1 0 N 0 0 0 0 0 0 0
47 19 0 1 0 N 1 0 1 0 0 0 0
48 27 0 1 0 N 1 0 0 0 0 0 0
49 25 0 1 0 N 0 0 0 0 0 0 0
50 31 0 1 0 N 1 0 0 0 0 0 0
51 18 0 1 0 N 1 0 0 0 0 0 0
52 32 0 1 0 N 1 0 0 0 0 0 0
53 27 0 1 0 N 0 0 0 0 0 0 0
54 26 0 1 0 N 1 1 2 1 0 0 1
55 25 0 1 0 N 1 0 0 0 0 0 0
56 26 0 1 0 N 0 0 0 0 0 0 0
57 24 0 1 0 N 1 0 0 0 0 0 0
58 23 0 1 0 N 1 0 2 0 0 0 0
59 24 0 1 0 N 0 0 0 0 0 0 0
60 23 0 1 0 N 0 0 0 0 0 0 0
CONTROL 
 MASTER CHART KEY 
GESTATIONAL AGE: 
<37 weeks-1 
>37 weeks-0 
COMPLICATION: 
No complication-0 
IUGR-1 
Increased S/D ratio-2 
INDUCTION: 
Spontaneous-0 
Induced-1 
NST: 
Foetal distress -1 
No foetal distress -0 
DELIVERY: 
Normal-0 
Instrumental-1 
Lscs-2 
LIQUOR: 
Clear-0 
Meconium stained-1 
APGAR SCORE: 
Score 7-9:0 
Score <7:1 
 
 BABY WEIGHT: 
>2.5 kg: 0 
<2.5 kg: 1 
NICU ADMISSION: 
Yes: 1 
No: 0 
 
 
 
 
